Who founded Sherlock Biosciences?

Sherlock Biosciences was founded by Rahul Dhanda, James Collins, David Walt in 2018.

Who are Sherlock Biosciences's investors?

Sherlock Biosciences's investors include Catalio Capital Management, LP, Illumina Ventures, GV (Google Ventures).

How much funding has Sherlock Biosciences raised?

Sherlock Biosciences has disclosed $112.8M raised across 2 rounds.

Where is Sherlock Biosciences headquartered?

Sherlock Biosciences is headquartered in Cambridge, US.

Sherlock Biosciences

Cambridge, US · Founded 2018 · Delaware corporation · 3 known investors

sherlock.bio ↗

Healthtech

Founders & leadership

Sherlock Biosciences was founded in 2018 by Rahul Dhanda, James Collins, and David Walt.

Rahul DhandaCo-founder

James CollinsCo-founderVenture Partner at Catalio Capital Management, LP

David Walt inCo-Founder and Director2017–2024Advisor at Illumina Ventures

Board

Issi Rozen inMember Board of Directors2019–2022Investor at GV (Google Ventures)

Investors · 3

Catalio Capital Management, LPNew York

Illumina VenturesFoster City

GV (Google Ventures)reportedMountain View · $250K – $50Mvia Issi Rozen · board

Reported raises · per SEC filings

Form D private placements

$112.8M disclosed across 2 rounds · 2019–2022

▶$80MraisedMar 2022 · 13 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Michael RubinDirector
Issi RozenDirector
David WaltDirector
James CollinsDirector
Bryan DechairoExecutive Officer, Director

Offering amount: $80M
Amount sold: $80M
First sale: Feb 2022
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$32.8MraisedApr 2019 · 10 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Rahul DhandaExecutive Officer, Director
James CollinsDirector
Issi RozenDirector
David WaltDirector

Offering amount: $33.8M
Amount sold: $32.8M
First sale: Apr 2019
Incorporated: Corporation, Delaware, 2018
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Sherlock Biosciences went on to found or lead other companies.

David R. WaltDirectorFounded Vizgen +4 Issi RozenDirectorFounded Verve Therapeutics

Competitors · 1

by search overlap

Danaher3 shared keywordsDanaher is a diversified conglomerate that operates a portfolio of businesses in life sciences, diagnostics, and related fields, guided by its Danaher Business System (DBS) operating model.

Companies competing with Sherlock Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken

Agency	Phase	Year	Amount
Department of Agriculture (USDA)	Phase I	2023	$175K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Sherlock Biosciences?: Sherlock Biosciences was founded by Rahul Dhanda, James Collins, David Walt in 2018.
Who are Sherlock Biosciences's investors?: Sherlock Biosciences's investors include Catalio Capital Management, LP, Illumina Ventures, GV (Google Ventures).
How much funding has Sherlock Biosciences raised?: Sherlock Biosciences has disclosed $112.8M raised across 2 rounds.
Where is Sherlock Biosciences headquartered?: Sherlock Biosciences is headquartered in Cambridge, US.